NCT00709202: Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain |
|
|
| Completed | 2 | 48 | US | Betahistine, Serc, Betaserc, Betaserk, Placebo Oral Tablet | Nathan Kline Institute for Psychiatric Research, Stanley Medical Research Institute | Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Bipolar I Disorder, Bipolar II, Bipolar NOS(Not Otherwise Specified), Psychotic Disorder Not Otherwise Specified, Autism Spectrum Disorder | 05/16 | 12/16 | | |